Delivery Order SPE2DR25D3012-SPE2DR26F4E7D
Award Date 1/8/26
Potential Completion Date 1/30/26
Potential Value $7.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 by the Defense Logistics Agency on August 5, 2025, for TEZSPIRE 210 MG/1.91 ML pen injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 26, 2025, with performance taking place at the contractor's Conshohocken facility. The award represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,409.34 by the Defense Logistics Agency on January 5, 2026, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 27, 2026, with performance taking place at the contractor's Conshohocken facility. The award carries no set-aside designation and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,879.12 by the Defense Logistics Agency on October 28, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract is a firm fixed price delivery order with an ultimate completion date of November 19, 2025, and was competitively awarded with no set-aside designation. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 18, 2025, with a ceiling value of $28,123.08 for TEZSPIRE 210 mg/1.91 ml pen injectors. This firm fixed price, non-competitive delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by October 9, 2025. The award represents a child contract under AmerisourceBergen's significant...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,469.78 by the Defense Logistics Agency on December 11, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 5, 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectables. This firm fixed price delivery order, valued at $4,939.58, is scheduled for completion by December 17, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 on July 21, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by August 11, 2025, with performance taking place at the company's Conshohocken facility. The contract was funded by the Defense Logistics Agency's Medical Supply Chain division to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for TEZSPIRE 210 mg/1.91 ml pens valued at $4,687.18 on June 12, 2025. This firm fixed-price, competitively awarded delivery order is set to be completed by July 7, 2025, with performance occurring at the contractor's Conshohocken facility. The contract was funded through the Defense Logistics Agency's Medical Supply Chain, which manages pharmaceutical...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors valued at $7,030.77, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with the Defense Logistics Agency. The product will be...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 18, 2025. The award supports the company's role as a critical pharmaceutical distributor within the federal medical supply chain, with performance originating from the vendor's...